144 related articles for article (PubMed ID: 24676997)
1. Down-regulation of Dicer expression in cervical cancer tissues.
Zhao H; Jin X; Su H; Deng X; Fang Y; Shen L; Xie C
Med Oncol; 2014 May; 31(5):937. PubMed ID: 24676997
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer.
He L; Wang HY; Zhang L; Huang L; Li JD; Xiong Y; Zhang MY; Jia WH; Yun JP; Luo RZ; Zheng M
Cell Death Dis; 2014 May; 5(5):e1205. PubMed ID: 24787017
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated expression of dicer and drosha in breast cancer.
Yan M; Huang HY; Wang T; Wan Y; Cui SD; Liu ZZ; Fan QX
Pathol Oncol Res; 2012 Apr; 18(2):343-8. PubMed ID: 21898071
[TBL] [Abstract][Full Text] [Related]
4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
5. Dicer, Drosha, and outcomes in patients with ovarian cancer.
Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
[TBL] [Abstract][Full Text] [Related]
6. The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer.
Wang WN; Chen Y; Zhang YD; Hu TH
Tumour Biol; 2013 Jun; 34(3):1865-71. PubMed ID: 23519840
[TBL] [Abstract][Full Text] [Related]
7. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
Vaksman O; Hetland TE; Trope' CG; Reich R; Davidson B
Hum Pathol; 2012 Nov; 43(11):2062-9. PubMed ID: 22647351
[TBL] [Abstract][Full Text] [Related]
8. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
[TBL] [Abstract][Full Text] [Related]
9. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
[TBL] [Abstract][Full Text] [Related]
10. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer.
Wu D; Tao J; Xu B; Li P; Lu Q; Zhang W
Mol Med Rep; 2012 Mar; 5(3):695-9. PubMed ID: 22179432
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Dicer in hepatocellular carcinoma.
Wu JF; Shen W; Liu NZ; Zeng GL; Yang M; Zuo GQ; Gan XN; Ren H; Tang KF
Med Oncol; 2011 Sep; 28(3):804-9. PubMed ID: 20405249
[TBL] [Abstract][Full Text] [Related]
13. Complexity in regulation of microRNA machinery components in invasive breast carcinoma.
Kwon SY; Lee JH; Kim B; Park JW; Kwon TK; Kang SH; Kim S
Pathol Oncol Res; 2014 Jul; 20(3):697-705. PubMed ID: 24574065
[TBL] [Abstract][Full Text] [Related]
14. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1.
Ueda R; Kohanbash G; Sasaki K; Fujita M; Zhu X; Kastenhuber ER; McDonald HA; Potter DM; Hamilton RL; Lotze MT; Khan SA; Sobol RW; Okada H
Proc Natl Acad Sci U S A; 2009 Jun; 106(26):10746-51. PubMed ID: 19520829
[TBL] [Abstract][Full Text] [Related]
15. Expression of Dicer and Drosha in triple-negative breast cancer.
Passon N; Gerometta A; Puppin C; Lavarone E; Puglisi F; Tell G; Di Loreto C; Damante G
J Clin Pathol; 2012 Apr; 65(4):320-6. PubMed ID: 22259182
[TBL] [Abstract][Full Text] [Related]
16. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
[TBL] [Abstract][Full Text] [Related]
19. Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.
Vincenzi B; Zoccoli A; Schiavon G; Iuliani M; Pantano F; Dell'aquila E; Ratta R; Muda AO; Perrone G; Brunelli C; Correale P; Riva E; Russo A; Loupakis F; Falcone A; Santini D; Tonini G
Eur J Cancer; 2013 Apr; 49(6):1501-8. PubMed ID: 23266047
[TBL] [Abstract][Full Text] [Related]
20. Expression of dicer and its related miRNAs in the progression of prostate cancer.
Bian X; Shen Y; Zhang G; Gu C; Cai Y; Wang C; Zhu Y; Zhu Y; Zhang H; Dai B; Ye D
PLoS One; 2015; 10(3):e0120159. PubMed ID: 25768283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
